muramidase has been researched along with Weight-Loss* in 4 studies
4 other study(ies) available for muramidase and Weight-Loss
Article | Year |
---|---|
Deletion of LysM in LysMCre Recombinase Homozygous Mice is Non-contributory in LPS-Induced Acute Lung Injury.
Lysozyme is an important component of the innate immune system and has roles in peptidoglycan cleavage of gram-positive organisms. Myeloid cells highly express the isoform, lysozyme M, and its promoter has been used to direct Cre recombinase expression to target deletion of floxed genes in myeloid cells. However, generation of the LysMCre mouse effectively disrupts the LysM gene, and mice homozygous for the Cre allele lack the LysM gene product. To test the contribution of LysM in sterile acute lung injury, we generated LysMCre mice homozygous for the Cre allele (+/+) or wild-type allele (-/-). These mice were challenged with LPS delivered via oropharygneal aspiration. Mice were monitored and weighed daily, and BAL cell counts, differential, protein, and cytokine levels were assessed at days 2 and 4. LysMCre+/+ and LysMCre-/- had similar weight loss and recovery, and similar inflammatory responses to LPS at days 2 and 4. These findings indicate that loss of LysM and expression of Cre recombinase are non-contributory in sterile acute lung injury. Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Chemokine CCL2; Chemokine CXCL1; Cytokines; Gene Targeting; Homozygote; Inflammation; Integrases; Lipopolysaccharides; Mice; Muramidase; Myeloid Cells; Real-Time Polymerase Chain Reaction; Recovery of Function; Weight Loss | 2019 |
Neurosarcoidosis.
Topics: Adult; Antirheumatic Agents; Appetite; Cell Count; Central Nervous System Diseases; Fatigue; Humans; Infliximab; Magnetic Resonance Imaging; Male; Muramidase; Proteins; Sarcoidosis; Weight Loss | 2018 |
A new lysozyme tyr54asn mutation causing amyloidosis in a family of Swedish ancestry with gastrointestinal symptoms.
Familial amyloidoses are a group of inherited disorders that cause deposition of misfolded amyloidogenic proteins in various tissues, resulting in organ dysfunction. Point mutations in the coding region of seven different genes are known to cause clinically significant systemic amyloid disease. We describe a new mutation in exon 2 of the lysozyme gene associated with amyloidosis (ALys) in a 61-year-old woman with a 7-year history of non-bloody, watery diarrhea, and weight loss. Biopsies of the duodenum and stomach were positive for amyloid deposits in the lamina propria and blood vessels. Direct DNA sequencing of the lysozyme gene revealed a single base nucleotide transversion from T to A at the first position of codon 54, resulting in replacement of Tyr by Asn in the mature lysozyme protein (pTyr54Asn). Immunoblot analysis of amyloid fibrils extracted from a fat tissue sample confirmed lysozyme as the amyloid protein. Clinically, the phenotype associated with this lysozyme mutation featured chronic abdominal pain, diarrhea, weight loss, malabsorption, and sicca syndrome. There was no associated nephropathy as has been reported for other ALys mutations. We describe a new mutant lysozyme that presents with abdominal discomfort, diarrhea, weight loss, and sicca syndrome. Topics: Amyloid; Amyloidosis, Familial; Biopsy; Diarrhea; Duodenum; Exons; Female; Gastric Mucosa; Humans; Middle Aged; Muramidase; Pedigree; Point Mutation; Sequence Analysis, DNA; Stomach; Weight Loss | 2012 |
[A-leukemic caecal myeloid sarcoma: a difficult diagnosis].
Myeloid sarcoma is a malignant neoplasia composed of abnormal myeloid or monocytic cells, often localized in bones, but also rarely in extra-medullary sites such as lymph nodes, skin and soft tissue. We report a case of caecal myeloid sarcoma, diagnosed in a 60 year old woman who complained from abdominal pain and weight loss, in absence of any medullary disorder. Initially misdiagnosed as a B lymphoma because of a weak positivity for CD79a, the diagnosis of primitive caecal myeloid sarcoma was eventually established after further investigations showing a positivity for lysozyme and myeloperoxidase. This report of such a rare clinical and pathological presentation of a myeloid sarcoma underlines a difficult differential diagnosis for which adequate immunohistochemistry, including lysozyme and myeloperoxydase is mandatory. Topics: Abdominal Pain; Antigens, CD; CD79 Antigens; Cecal Neoplasms; Diagnosis, Differential; Female; Humans; Immunohistochemistry; Leukemia, Myeloid; Middle Aged; Muramidase; Peroxidase; Receptors, Antigen, B-Cell; Weight Loss | 2004 |